Investigation Report on China Doxofylline Market, 2010-2019

With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of…
Reference: 1506214
Price: $2,000.00
Tax included

General

Publisher:
CRI
Geography Covered
China
Publication Date
6/11/2015
Pages
30
Version:
2010
Charts:
30
Language
  • English
  • Chinese
Format
License

Description

With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the incidence of all diseases. About 280 million people in the world suffer from different degrees of seasonal asthma. The situation is more serious in industrialized countries and regions where tobacco consumption is high with 5% of adults and 20% of children there having been attacked by this disease. Nearly 300 million people in China contract respiratory ailments, among which over 50 million suffer from cough with an annual growth rate of 4% and 15-20 million asthma.
Doxofylline, a derivative of theophylline, is a methylxanthine anti-bronchospasm drug for the treatment of bronchial asthma, panting chronic bronchitis and breathing difficulties caused by other bronchospasm. It is also a common drug for acute and chronic obstructive airway disorders. Unlike other methylxanthines, dexofylline has no side effects on gastrointestinal tract, nervous system, heart and kidney. First developed and marketed by ITALY and ABC company in 1988, doxofylline has now become the best-selling drug in many countries like the US, Japan, Ireland and Canada. Chinese enterprises begun manufacturing improvements in 1992 and has now developed such dosage forms as syrup, tablet, injection and APIs. Compared with traditional theophylline and aminophylline, doxofylline has better efficacy and less toxicity and therefore is worthwhile for spreading in clinical practice.
Doxofylline develops fast after entering China, annual sales value rising from CNY 124 million in 2010 to CNY 224 million in 2014 and CAGR reaching up to 15.9% during the period of 2010-2014. Doxofylline enjoys a vast demand in China. Currently, Fuhe Huaxing Pharmaceutical Shares Co., Ltd, Xi’an Bosen BioPharma Co., Ltd, Zhejiang Hansheng Pharmaceutical Co., Ltd of Beisheng Pharma, Kaifeng Canon Pharmaceutical Co., Ltd and ReYoung Pharmaceutical Co., Ltd all take up certain shares in the market, among which Fuhe Huaxing Pharmaceutical Shares Co., Ltd has the largest market share of 27.8% with sales value in 2014 reaching up to CNY 62.33 million.
As environmental pollution worsens in China, the incidence of respiratory ailments will keep growing. Therefore, the market size of doxofylline in China is expected to keep expand in the next few years.

Readers can get at least the following information from this report:
-market size of doxofylline in China
-market share of manufacturers of doxofylline in China
-price of doxofylline in Chinese market
-major manufacturers of doxofylline in Chinese market
-market outlook of doxofylline in China

The author suggests the following groups of people purchase this report:
-manufacturers of respiratory drugs
-investors/ research institutions interested in Chinese medicine market
-any interest in the Chinese medicine market, please contact CRI for customized survey service
Table of Contents

1 Related Concepts of Doxofylline
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Doxofylline in China
2.1 Patent and Approval Status of Doxofylline in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Doxofylline in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Doxofylline in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Doxofylline in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Doxofylline in Chinese Hospitals in 2014
6.1 Shanghai Kai Bao Pharmaceutical Co., Ltd
6.2 Shandong Qidu Pharmaceutical Co., Ltd
6.3 ReYoung Pharmaceutical Co., Ltd
6.4 Kaifeng Canon Pharmaceutical Co., Ltd
6.5 Zhejiang Hansheng Pharmaceutical Co., Ltd of Beisheng Pharma
6.6 Southwast Pharmaceutical Co., Ltd
6.7 Xi’an Bosen BioPharma Co., Ltd
6.8 Fuhe Huaxing Pharmaceutical Shares Co., Ltd

7 Major Manufacturers of Doxofylline in Chinese Market, 2010-2014
7.1 Fuhe Huaxing Pharmaceutical Shares Co., Ltd
7.2 Xi’an Bosen BioPharma Co., Ltd
7.3 Zhejiang Hansheng Pharmaceutical Co., Ltd of Beisheng Pharma
7.4 Kaifeng Canon Pharmaceutical Co., Ltd
7.5 ReYoung Pharmaceutical Co., Ltd

8 Market Outlook of Doxofylline in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

Selected Charts
Chart Patent Status of Doxofylline in China
Chart Approval Information of Doxofylline in China
Chart Sales Status of Doxofylline in China, 2010-2014
Chart Sales Value of Doxofylline in China, 2010-2014
Chart Sales Value of Doxofylline in Some Regions in China, 2010-2014
Chart Sales Volume of Doxofylline in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Doxofylline for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Doxofylline Made by Fuhe Huaxing in China, 2010-2014
Chart Sales Value and Market Share of Doxofylline Made by ReYoung in China, 2010-2014
Chart Sales Value and Market Share of Doxofylline Made by Kaifeng Canon in China, 2010-2014
Chart Sales Value and Market Share of Doxofylline Made by Xi’an Bosen BioPharma in China, 2010-2014
Chart Sales Value and Market Share of Doxofylline Injections in China, 2010-2014
Chart Sales Value and Market Share of Doxofylline Tablets in China, 2010-2014
Chart Sales Value and Market Share of Doxofylline Capsules in China, 2010-2014
Chart Sales Value and Market Share of Doxofylline Granules in China, 2010-2014
Chart Price of Doxofylline Made by Shanghai Kai Bao Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Doxofylline Made by Shandong Qidu Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Doxofylline Made by ReYoung Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Doxofylline Made by Kaifeng Canon Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Doxofylline Made by Zhejiang Hansheng Pharmaceutical Co., Ltd of Beisheng Pharma in Some Chinese Cities in 2014
Chart Price of Doxofylline Made by Southwast Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Scroll